ZELTIQ Aesthetics, Inc. to Present at Leerink Partners 6th Annual Global Healthcare Conference

PLEASANTON, Calif., Feb. 01, 2017 -- ZELTIQ® (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Taylor Harris, Senior Vice President and Chief Financial Officer, are scheduled to present at Leerink Partners 6^th Annual Global Healthcare Conference in New York, NY. The Leerink Conference will utilize a fireside chat format for the presentation.

Audio webcast of the Company’s presentation will be available by visiting the investor relations section of ZELTIQ’s web site at www.coolsculpting.com. A replay of the presentation will be available for 90 days.

About ZELTIQ® Aesthetics
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ’s first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.

MEDIA CONTACT:                               
Jill Knepper
Ketchum for ZELTIQ
310-437-2517                               

INVESTOR RELATIONS:
Taylor Harris
ZELTIQ, Senior Vice President and CFO
925-474-2500

Nick Laudico
The Ruth Group for ZELTIQ
646-536-7030